Empowering Mothers in the NICU

NCT ID: NCT06958458

Last Updated: 2025-09-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

54 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-08-30

Study Completion Date

2025-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Family Integrated Care is designed to eliminate the barriers between parents and their infants in the NICU by involving parents of premature infants in their care. Parents are integrated into both the healthcare team and the care of their infant. Through this approach, parents are informed about how they can contribute to their infant's overall development, including neurological and sensory development, motor and behavioral progress, as well as practices such as touch, bonding, skin-to-skin contact, breastfeeding, and increasing breast milk production. They are also educated on general hygiene and care tasks such as diaper changing and body cleaning. This model places importance on the protection and enhancement of both the physical and psychological well-being of the parent and the infant. During this process, parents move beyond being mere "visitors" in the unit to becoming active "participants" and members of the care team. Family integrated care aims to support parents in becoming the primary caregivers for their infants, both during hospitalization and after discharge. This model not only provides education and counseling but also supports the family's comprehensive involvement in the infant's care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mothers Premature Empowerment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This is a randomized controlled trial (RCT) designed to evaluate the effectiveness of an intervention.
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mother Integrated Care Group

Mothers whose infants are admitted to the NICU will be contacted within the first 72 hours. Pre-test data (Information Form, Maternal Attachment Scale, and Parental Stressor Scale: Neonatal Intensive Care Unit) will be collected, and education will be planned through a face-to-face interview.

After meeting with the mother and administering the pre-test, the training date will be scheduled together with the researchers.

The training, which consists of four steps, is planned to be conducted with a two-day interval between each session.

The practices will be demonstrated on mannequins and supported by a PowerPoint presentation and visual materials. A booklet prepared specifically for the mothers will also be distributed.

After the training steps are completed, mothers will be encouraged to participate in their infant's care in cooperation with the NICU team.

One day before discharge and one week after discharge, questionnaire forms will be administered via WhatsApp.

Group Type EXPERIMENTAL

Mother Integrated Care

Intervention Type BEHAVIORAL

In order to empower mothers whose premature infants have been hospitalized in the neonatal intensive care unit (NICU) for at least three days, a four-step neonatal care training program will be provided. Through the empowerment of the mother, the empowerment of the family will also be supported. The family will no longer be considered as visitors but will be involved in the infant's care in the NICU as parents. Data collection forms will be completed before the training begins, one day prior to discharge, and one week after discharge.

Control group

Mothers in this group will receive standard unit care and education. Data collection procedures will be the same as those used in the intervention group. The mother will be contacted within the first 72 hours of admission to the unit, and pre-test data will be collected. One day before discharge and one week after discharge, questionnaire forms will be administered via WhatsApp.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mother Integrated Care

In order to empower mothers whose premature infants have been hospitalized in the neonatal intensive care unit (NICU) for at least three days, a four-step neonatal care training program will be provided. Through the empowerment of the mother, the empowerment of the family will also be supported. The family will no longer be considered as visitors but will be involved in the infant's care in the NICU as parents. Data collection forms will be completed before the training begins, one day prior to discharge, and one week after discharge.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The newborn must be premature (gestational age \>28 and \<34 weeks),
* The infant must be admitted to the NICU and hospitalized for at least 3 days,
* The mother must be open to communication and cooperation,
* The mother must voluntarily agree to participate in the study,
* The mother must be literate,
* The mother must be able to speak and understand Turkish,
* The mother must be primiparous and experiencing motherhood for the first time,
* The mother must be over 18 years of age,
* Mothers in the intervention group must be present in the hospital for an average of 6-8 hours per day.

Exclusion Criteria

* The newborn has a congenital anomaly (e.g., craniofacial anomalies such as cleft palate, cleft lip, or facial muscle paralysis),
* The newborn has a diagnosed gastrointestinal, neurological, or genetic disorder (e.g., necrotizing enterocolitis, hydrocephalus, Down syndrome, omphalocele, gastroschisis, short bowel syndrome, or other diseases),
* The newborn has a congenital heart defect requiring surgical intervention,
* The mother has a diagnosed psychiatric illness,
* The mother and/or father do not wish to participate in the study.

Withdrawal Criteria:

* The mother does not attend the training sessions during the study period,
* The mother fails to maintain cooperation throughout the study,
* The newborn is transferred to another healthcare center for any reason,
* The mother wishes to withdraw from the study,
* The newborn is diagnosed with a chronic illness during the study process.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Yalova

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Emel AVÇİN

Lecturer Dr

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

EMEL AVÇİN, Doctor

Role: PRINCIPAL_INVESTIGATOR

University of Yalova

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Yalova University

Yalova, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

EMEL AVÇİN, Doctor

Role: CONTACT

05534524243

ŞEYDA CAN, Ass Professor

Role: CONTACT

05366850312

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yalova Provincial Health Directorate

Role: primary

0226 817 74 07

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Emel A. Family Integrated Care

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.